Evidence map›Paper›PMID 28228804›Full record

ArticleIranian journal of pharmaceutical research : IJPR2016

Synthesis of Some Spiro Indeno[1,2-

Ghodsi Mohammadi Ziarani, Shima Asadi, Alireza Badiei, Amirhossein Sharifi, Massoud Amanlou

Abstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ghodsi Mohammadi ZiaraniDepartment of Chemistry, Alzahra University, Vanak Square, Tehran, Iran.; National Laboratory of Pharmaceutical Research, Alzahra University, Tehran, Iran .
Shima AsadiDepartment of Chemistry, Alzahra University, Vanak Square, Tehran, Iran.
Alireza BadieiSchool of Chemistry, College of Science, University of Tehran, Tehran, Iran.
Amirhossein SharifiDrug Design and Development Research Centre and Department of Medicinal Chemistry, Faculty of Pharmacy, TehranUniversity of Medical Sciences, Tehran, Iran.
Massoud AmanlouDrug Design and Development Research Centre and Department of Medicinal Chemistry, Faculty of Pharmacy, TehranUniversity of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New series of spiro indeno[1,2-

Indexed as

AutodockBiacidic nano catalystMulticomponent reaction (MCR)Spiro indenopyridopyrimidineUrease inhibitor

Identifiers

PMID28228804
PMCPMC5242352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.